2026年10月16日，华润医药集团有限公司（03320.HK）公告称，其非全资附属公司华润医药商业集团有限公司已依据《企业国有资产交易监督管理办法》相关规定，通过北京产权交易所启动公开投标方式发行新股份的投标前程序。
公告披露，华润医药商业已于2026年10月16日在北京产权交易所网站（www.cbex.com.cn）发布增资信息预披露申请书。新股份发行数量及募集资金规模将结合市场条件等因素适时确定。
公司强调，目前尚未就本次潜在发行签署任何具约束力协议，后续实施仍需完成北京产权交易所的正式公开投标程序。若有进一步进展，华润医药将依据香港联合交易所有限公司证券上市规则及香港《证券及期货条例》第XIVA部的相关规定另行公告。
公司提醒投资者在买卖公司证券时需保持审慎。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.